The industry is expected to break its lobbying record after spending tens of millions of dollars to undermine a popular proposal to reduce prescription drug costs.

By Kenny Stancil.  Published 11-5-2021 by Common Dreams

Photo: Daniel Foster/flickr/CC

While progressive advocates are still optimistic that a limited drug pricing provision will be included in the Build Back Better Act, the Washington Post on Friday detailed the “massive, months-long advertising, lobbying, and political donation blitz” that Big Pharma and its allies carried out to kill a stronger and overwhelmingly popular proposal that would have done more to protect Americans from the industry’s deadly price gouging.

As Common Dreams has reported, pharmaceutical corporations and private health insurers spent $171 million on lobbying through the first nine months of the year, the most of any industry. Big Pharma’s 1,600 lobbyists outnumber members of Congress by a ratio of three to one. Continue reading →